Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity
- PMID: 9581787
- DOI: 10.1006/viro.1998.9079
Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity
Abstract
It is largely unknown whether hepatitis B virus (HBV) sequence variation during chronic infection hampers HBV immune recognition or the antiviral effect of cytokines on HBV production. Here we have analyzed which region of the HBV genome changes most drastically during an interferon-alpha (IFNalpha)-stimulated immune response. In addition, we have investigated whether the mutations affect viral replication, gene expression, and immune recognition of the mutant viral proteins. The study was performed with full-length HBV genomes taken longitudinally from a patient who transiently cleared HBV and seroconverted to anti-HBe during a long-term IFNalpha treatment. We found a replacement of the predominant virus population during IFNalpha therapy The virus populations differed mainly by a cluster of nucleotide changes in the C-gene and a pre-S2 deletion. Most of the newly emerging mutations localized within core/HBe B-cell epitopes, changed HBe antigenicity toward mono- and polyclonal antibodies, and also influenced the reactivity of the anti-HBc/e antibodies of the patient. All genomes tested expressed less HBeAg than wild-type HBV, while replication and IFNalpha susceptibility were similar. These data indicate that IFNalpha therapy can lead to the emergence of HBV variants with mutations mainly affecting recognition of the core/HBe proteins by antibodies. Taken together, the type of core/HBe-specific B-cell immune response, the sequence of the corresponding epitopes, and the HBe expression level appear to contribute to the decision on viral clearance or persistence.
Similar articles
-
Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.Virology. 1992 Mar;187(1):271-9. doi: 10.1016/0042-6822(92)90315-g. Virology. 1992. PMID: 1736529
-
Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.Virology. 1990 Jun;176(2):596-603. doi: 10.1016/0042-6822(90)90030-u. Virology. 1990. PMID: 2345966
-
Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.J Med Virol. 1996 Jan;48(1):8-16. doi: 10.1002/(SICI)1096-9071(199601)48:1<8::AID-JMV2>3.0.CO;2-E. J Med Virol. 1996. PMID: 8825704
-
[Hepatitis B virus mutants--clinical significance].Z Gastroenterol. 1997 May;35(5):347-55. Z Gastroenterol. 1997. PMID: 9265394 Review. German.
-
[Genotypic changes in the precore region of HBV-DNA in chronic hepatitis B patients who seroconverted from HBe Ag to anti-HBe after interferon treatment].Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):195-200. Nihon Rinsho. 1995. PMID: 12442385 Review. Japanese. No abstract available.
Cited by
-
Mutations and methods of analysis of mutations in Hepatitis B virus.AIMS Microbiol. 2020 Oct 27;6(4):401-421. doi: 10.3934/microbiol.2020024. eCollection 2020. AIMS Microbiol. 2020. PMID: 33364535 Free PMC article. Review.
-
HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.Oncotarget. 2016 Feb 23;7(8):9448-61. doi: 10.18632/oncotarget.7021. Oncotarget. 2016. PMID: 26824500 Free PMC article.
-
Influence of a putative intermolecular interaction between core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion.J Virol. 2002 Jul;76(13):6510-7. doi: 10.1128/jvi.76.13.6510-6517.2002. J Virol. 2002. PMID: 12050364 Free PMC article.
-
Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany.Virus Genes. 2002 Mar;24(2):153-6. doi: 10.1023/a:1014572600432. Virus Genes. 2002. PMID: 12018706
-
Molecular, immunological and clinical properties of mutated hepatitis B viruses.J Cell Mol Med. 2002 Jan-Mar;6(1):113-43. doi: 10.1111/j.1582-4934.2002.tb00317.x. J Cell Mol Med. 2002. PMID: 12003675 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical